Novo A/S Launches a New Investing Initiative

Growth Equity is being launched now in response to the overwhelming need for development capital in smaller life science companies internationally, and has been catalyzed by the recent developments in the financial markets. Ulrik Spork, Managing Partner, Growth Equity, Novo A/S, explains.